Clemens Kratochwil

9PUBLICATIONS
12CO-AUTHORS
PharmacogenomicsNuclear and plasma physics not elsewhere classifiedMolecular targetsAcceleratorsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).

Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber

|Feb 13, 2023
Liver metastasis of a neuroendocrine tumor demonstrates intense uptake in PSMA-PET-but not its lymph-node metastasis and primary-tumor.

Erik Winter, Stefanie Zschäbitz, Clemens Kratochwil

|Jan 03, 2023
FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease.

Yuriko Mori, Katharina Dendl, Jens Cardinale

|Mar 17, 2021
[153Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma.

Clemens Kratochwil, Frederik L Giesel, Hendrik Rathke

|May 24, 2019
FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis.

Frederik L Giesel, Claus Peter Heussel, Thomas Lindner

|Jan 04, 2019
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?

José Carlos Dos Santos, Martin Schäfer, Ulrike Bauder-Wüst

Pageof 2

Frequent Collaborators

1 joint publications

Jianquan Yang

1 joint publications

Thomas Lindner

1 joint publications

Yubin Miao

1 joint publications

Yuriko Mori